NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $24.81 +0.32 (+1.31%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatings About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get REVS alerts:Sign Up Key Stats Today's Range$24.60▼$24.9150-Day Range$24.49▼$26.9952-Week Range$21.22▼$27.03Volume9,527 shsAverage Volume13,200 shsMarket Capitalization$44.66 millionAssets Under Management$60.11 millionDividend Yield1.93%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.Read More… Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.55%0.51%0.52%Other Expenses0.00%0.31%0.49%0.57%0.53%Total Expense0.19%0.65%0.71%0.73%0.71%Fee Waiver0.00%-0.26%-0.51%-0.67%-0.56%Net Expense0.19%0.62%0.61%0.58%0.59% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address REVS ETF News HeadlinesREVS Columbia Research Enhanced Value ETFOctober 17, 2024 | seekingalpha.comFEPY ETF: Combining Income and Growth Opportunities for Canadian InvestorsOctober 2, 2024 | theglobeandmail.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.December 22, 2024 | Crypto Swap Profits (Ad)Columbia Thermostat A CTFAXAugust 14, 2024 | morningstar.comThe Zacks Analyst Blog Highlights IBM, Amazon.com and MicrosoftAugust 13, 2024 | uk.finance.yahoo.comColumbia Banking System declares $0.36 dividendFebruary 9, 2024 | msn.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $21.65 at the start of the year. Since then, REVS stock has increased by 14.6% and is now trading at $24.81. View the best growth stocks for 2024 here. Who are Columbia Research Enhanced Value ETF's major shareholders? Top institutional shareholders of Columbia Research Enhanced Value ETF include Wealth Enhancement Advisory Services LLC (2.15%), Pine Valley Investments Ltd Liability Co (1.58%) and Jane Street Group LLC (0.62%). How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Columbia Research Enhanced Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include The GEO Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY). Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings312 Fund Statistics Assets Under Management$60.11 million Average Daily Volume$0.00 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorColumbia Management Investment Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest3,000 shs Miscellaneous Outstanding Shares1,800,000Beta0.76 Creation Unit50,000 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Top 10 REVS HoldingsJPMorgan Chase & Co. (NYSE:JPM)Holding Weight: 5.46%Johnson & Johnson (NYSE:JNJ)Holding Weight: 4.57%Cisco Systems (NASDAQ:CSCO)Holding Weight: 3.44%Exxon Mobil (NYSE:XOM)Holding Weight: 2.98%Bank of America (NYSE:BAC)Holding Weight: 2.97%Wells Fargo & Company (NYSE:WFC)Holding Weight: 2.49%Philip Morris International (NYSE:PM)Holding Weight: 2.45%Caterpillar (NYSE:CAT)Holding Weight: 1.79%Chevron (NYSE:CVX)Holding Weight: 1.58%Bristol-Myers Squibb (NYSE:BMY)Holding Weight: 1.44%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.